Business Wire

New Method Enables Structural Determination of Diverse Phenolic Compounds from a Tiny Alpine Flower Sample

15.4.2026 17:00:00 EEST | Business Wire | Press release

Share

Hyuga Hirano (United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology, and collaborative graduate student at the National Museum of Nature and Science (President: Makoto Manabe)); Takashi Kikuchi (Application Laboratories, Global Product Unit, Rigaku Corporation, a group company of Rigaku Holdings); Futa Sakakibara (Technical Advisor, R&D Support Division, Asterism G.K.); Yoshinori Murai (Senior curator, Department of Botany, National Museum of Nature and Science); and colleagues have successfully determined the structures of more than ten phenolic glycosides from a tiny sample of an alpine plant flower by developing a trace analysis method. This achievement is particularly significant because alpine plants are typically small and difficult to collect due to legal, ethical, and environmental considerations, resulting in extremely limited sample availability. Determining the structures of numerous chemical components from such a small sample represents a pioneering research accomplishment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415694539/en/

Figure 1: Pincushion plant (Diapensia lapponica) in bloom, growing in alpine rocky areas. Its distribution in Japan extends from the Chubu region of Honshu to Hokkaido.

The method developed by the research team can be applied not only to the analysis of plant chemical constituents, but also to the exploration of underutilized resources across a wide range of fields, including physics, agriculture, and pharmaceutical sciences.

The research results were published online on February 22, 2026, in the online Journal of Molecular Structure. Related studies employing similar techniques have also been published in Biochemical Systematics and Ecology.

Research Summary:

  • A method of isolating and crystallizing trace chemical components was established.
  • Structural analysis of crystallized components was successfully achieved using analytical techniques such as single-crystal X-ray diffraction (SC-XRD) and microcrystal electron diffraction (MicroED).
  • Using this approach, structural determination of phenolic compounds was successfully conducted in alpine plants for which research samples are difficult to obtain, revealing a diverse range of phenolic compounds present in the flowers of Diapensia lapponica.
  • During the development of this method, related studies also led to the discovery of components associated with chemical adaptive mechanisms and phylogenetic characteristics in plants.

1. Background and Results

Alpine plants are distributed throughout Japan’s alpine and subalpine zones. To withstand the environmental stresses characteristic of alpine environments, such as intense ultraviolet radiation and low temperatures, these plants adapt by synthesizing and accumulating chemical compounds known as phenolic compounds. Many phenolic compounds are also recognized as potential natural resources. As alpine plants remain less well studied than lowland plants, further research in this field is particularly anticipated. At the same time, the harsh environments in which alpine plants grow result in small plant size. In addition, their distribution is restricted to high-altitude regions, making them relatively rare. Even in academic research, legal, permitting, and ethical considerations require that plant collection be strictly limited to minimize human disturbance to alpine ecosystems. Consequently, the amount of sample material available for structural analysis is extremely limited.

The research team had been developing a method for analyzing the components of trace samples. In this study, using a very small sample of flowers of the alpine plant Diapensia lapponica, the team isolated and purified individual components using high-performance liquid chromatography (HPLC) and determined their molecular weights by quadrupole time-of-flight mass spectrometry (QTOF-MS). The team then developed a method to optimize the crystallization of each component.

By applying analytical techniques such as single-crystal X-ray diffraction (SC-XRD) and microcrystal electron diffraction (MicroED), which enable structural determination from crystals approximately one hundredth the size required by conventional methods, the team successfully determined the structures of trace components from extremely small samples. The results demonstrated that D. lapponica, which thrives in harsh alpine environments, contains flavonoids and other phenolic compounds, including quercetin glycosides. These compounds have attracted attention in recent years as functional ingredients with potential health benefits.

In related research published in Biochemical Systematics and Ecology, the research team also succeeded in isolating and determining the structures of numerous components from the leaves of the same plant, discovering compounds that contribute to ultraviolet protection and antioxidant activity. The study further revealed that the accumulation of some components differs geographically, from the Chubu region of Honshu to Hokkaido. The present study represents an advancement of these earlier findings.

2. Notes

High-performance liquid chromatography (HPLC): An analytical technique that separates and detects components based on differences in their interactions with a mobile phase (solvent) and a stationary phase (column). The preparative HPLC system shown in Figure 2 was used to isolate each component.

Quadrupole time-of-flight mass spectrometry (QTOF-MS): A mass spectrometry technique that combines quadrupole and time-of-flight analyzers to achieve high mass accuracy, resolution, and sensitivity. The LC-QTOF-MS system shown in Figure 2 integrates HPLC with QTOF-MS.

Single-crystal X-ray diffraction (SC-XRD): A method in which sample crystals are irradiated with an X-ray beam, and the resulting diffraction pattern is used to directly determine the three-dimensional molecular structure.

Microcrystal electron diffraction (MicroED): A structural analysis technique that uses an electron beam instead of X-rays, enabling structure determination from much smaller, submicrometer-sized crystals.

3. Future Directions

In developing the analytical method described here, the research team used samples from the pincushion plant, an alpine species with a relatively wide geographical distribution. The team is currently applying this method to the analysis of rarer plant species, including species endemic to Japan and endangered species.

This approach is expected to facilitate the identification of trace components in plants that have previously been difficult to analyze, as well as the exploration of novel and underutilized biological resources. Furthermore, the method has broad applicability across diverse fields, including physics, agricultural science, and pharmaceutical sciences, and is expected to serve as an important source of foundational information for both basic and applied research.

4. Presented Papers

Title: Sustainable micro-scale identification of phenolic glycosides in alpine flower through single-crystal structure analysis
Authors: Hyuga Hirano, Takashi Kikuchi, Futa Sakakibara, Yoshinori Murai
Publication: Journal of Molecular Structure, 145740 (online February 22, 2026)

Related paper
Title: Phenolic compound diversity reflecting phylogeographic structure of Diapensia lapponica subsp. obovata (Diapensiaceae) populations in Japan
Authors: Hyuga Hirano, Toshiyo Kato, Keiichi Noguchi, Hisahiro Kai, Takuro Ito, Takashi Kikuchi, Futa Sakakibara, Yoshinori Murai
Publication: Biochemical Systematics and Ecology, 125: 105168 (online November 20, 2025; scheduled for print release in April 2026)

This research was supported by a Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers JP23K05503 and JP24KJ1011, and “Integrated Research on Extreme Environments” of the National Museum of Nature and Science, Japan.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260415694539/en/

Contacts

(Inquiries regarding research)
Sawa Himeno
Director, Communication Dept
Rigaku Holdings Corporation
E-mail: prad@rigaku.co.jp

Yoshinori Murai
Senior curator, Department of Botany, National Museum of Nature and Science
Associate professor, Tokyo University of Agriculture and Technology
E-mail: murai@kahaku.go.jp

Futa Sakakibara
Technical advisor, R&D Support Division
Asterism G.K.
E-mail: lab@asterism.co.jp
Website: https://www.asterism.co.jp -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.asterism.c
o.jp%2F&esheet=54511894&newsitemid=20260415694539&lan=en-US&anchor=https%3A%2F%2
Fwww.asterism.co.jp&index=1&md5=901509db40ccc9bb87379ef7b6753b4b

(Media Inquiries)
Sawa Himeno
Director, Communication Dept.
Rigaku Holdings Corporation
E-mail: prad@rigaku.co.jp

Yuichi Inaba
Media contact on research activities, Research Advancement and Administration
Section, Business Administration Department
National Museum of Nature and Science
E-mail: t-shuzai@kahaku.go.jp TEL: +81-29-853-8984 FAX: +81-29-853-8998

Honoka Midorikawa
Contact for Asterism G.K., XiS WORKSITE
XiS INC.
E-mail: xis_worksite@orientalgiken.co.jp
TEL: +81-90-2524-8753
Website: https://www.orientalgiken.co.jp/xis_worksite -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.orientalgi
ken.co.jp%2Fxis_worksite&esheet=54511894&newsitemid=20260415694539&lan=en-US&anc
hor=https%3A%2F%2Fwww.orientalgiken.co.jp%2Fxis_worksite&index=2&md5=367e7dc8c92
909f2de268d27e70c19ac

Tokyo University of Agriculture and Technology
Public Relations Office
E-mail: koho2@cc.tuat.ac.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye